This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Varley, J., Evans, D. & Birch, J. Li-Fraumeni syndrome – a molecular and clinical review. Br J Cancer 76, 1–14 (1997). https://doi.org/10.1038/bjc.1997.328
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.328
This article is cited by
-
Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers
Nature Communications (2021)
-
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Hereditary Cancer in Clinical Practice (2020)
-
Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis
Laboratory Investigation (2019)
-
Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients
Cancer Imaging (2018)
-
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
Cell Death & Disease (2017)